Translational Micro- and Nanofluidic Technologies for Clinical Diagnostics: From Development to Real-World Applications
A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Nano- and Micro-Technologies in Biosensors".
Deadline for manuscript submissions: 1 May 2026 | Viewed by 1418
Special Issue Editor
Special Issue Information
Dear Colleagues,
Microfluidic and nanofluidic technologies are advancing clinical diagnostics through precise, efficient, and miniaturized analyses, significantly reducing sample/reagent consumption while accelerating assay times via automation—enabling transformative applications in point-of-care testing and low-resource settings. Advances in chip design, materials engineering, and system integration have yielded compact, cost-effective devices with heightened clinical viability. This Special Issue highlights cutting-edge developments in micro/nanofluidic platforms for clinical diagnostics, emphasizing translational applications that bridge laboratory innovation and real-world implementation for biomarker detection including blood typing, tumor marker identification, infectious disease screening, and chronic disease monitoring. Priority will be given to submissions demonstrating 1) translational research with robust clinical validation pathways, 2) high-throughput systems enabling multiplexed biomarker analysis, and 3) integrated point-of-care platforms with minimal hardware dependency—all converging toward enhanced early diagnosis, personalized healthcare, and accessible diagnostics in resource-limited environments.
The objective of this Special Issue is to gather high-quality original research and reviews showcasing micro/nanofluidic innovations with demonstrable clinical translation impact. We foster interdisciplinary collaboration among engineers, chemists, material scientists, biologists, and clinicians to accelerate real-world implementation of these systems in diagnostic workflows. Contributions are particularly encouraged where they advance 1) clinical validation pathways bridging bench-to-bedside gaps, 2) scalable device architectures supporting point-of-care deployment, and 3) regulatory-compliant frameworks ensuring clinical adoption—collectively driving accessible, precision-enhanced diagnostics forward.
We invite submissions to this Special Issue advancing micro/nanofluidic research with clinical translation impact, including but not limited to, the following: chip design/fabrication strategies for clinical biomarker detection (e.g., cancer, infectious diseases); integration of electrochemical/optical biosensing modalities with automated sample preparation; lab-on-a-chip/point-of-care platforms, particularly wearable/portable formats validated in real-world settings; cost-efficient manufacturing processes enabling scaled production; exosome/single-cell analysis systems; and clinical performance evaluation studies. Comprehensive reviews addressing translational challenges—from material integration bottlenecks to regulatory pathways—are equally encouraged to catalyze field-wide advancement in this rapidly evolving domain.
We look forward to receiving your contributions.
Dr. Rui Hu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- micro/nanofluidic
- clinical diagnostics
- point-of-care diagnostics
- translational medicine
- biomarker detection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
